Influence of SGLT2 inhibitors on plasma glycemic fluctuations and oxidative stress in patients with newly diagnosed type 2 diabetes mellitus

被引：0
|
作者：
Zhou, Peihua [1 ]
Ma, Jianhua [1 ]
Li, Fengfei [1 ]
机构：
[1] Nanjing First Hosp, Nanjing, Jiangsu, Peoples R China
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2016年 / 32卷 / SUPP 2期
关键词：
SGLT2; inhibitors; dapagliflozin; T2DM; blood glycemic fluctuations; oxidative stress;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
384458
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [41] SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus
    Ghosh, Raktim Kumar
    Ghosh, Samhati Mondal
    Chawla, Shalini
    Jasdanwala, Sarfaraz Abdeli
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (04): : 457 - 463
  • [42] Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion
    Hattersley, Andrew T.
    Thorens, Bernard
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (10): : 974 - 976
  • [43] Impact of SGLT2 Inhibitors on Lipoproteins in Type 2 Diabetes
    Corral, Pablo
    Nardelli, Natalia
    Elbert, Alicia
    Aranguren, Florencia
    Schreier, Laura
    CURRENT DIABETES REPORTS, 2025, 25 (01)
  • [44] Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes
    Muskiet, Marcel H. A.
    van Bommel, Erik J. M.
    van Raalte, Daniel H.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (03): : 188 - 189
  • [45] SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?
    Saisho, Yoshifumi
    DISEASES, 2020, 8 (02)
  • [46] SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases
    Wanner, Christoph
    Marx, Nikolaus
    DIABETOLOGIA, 2018, 61 (10) : 2134 - 2139
  • [47] The role of SGLT2 inhibitors in managing type 2 diabetes
    Tat, Velen
    Forest, Christopher P.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2018, 31 (06): : 35 - 40
  • [48] Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus
    Harold Bays
    Diabetes Therapy, 2013, 4 : 195 - 220
  • [49] SGLT2 Inhibitors in Type 2 Diabetes Mellitus and Heart Failure-A Concise Review
    Keller, Daria M.
    Ahmed, Natasha
    Tariq, Hamza
    Walgamage, Malsha
    Walgamage, Thilini
    Mohammed, Azad
    Chou, Jadzia Tin-Tsen
    Kaluzna-Oleksy, Marta
    Lesiak, Maciej
    Straburzynska-Migaj, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
  • [50] SGLT2 inhibitors with cardiovascular benefits: Transforming clinical care in Type 2 diabetes mellitus
    d'Emden, Michael
    Amerena, John
    Deed, Gary
    Pollock, Carol
    Cooper, Mark E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 136 : 23 - 31
12345